Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Hypersensitivity Reaction

  Free Subscription


23.09.2024

1 Acta Derm Venereol
4 Allergy
1 Allergy Asthma Proc
4 Am J Respir Crit Care Med
20 Ann Allergy Asthma Immunol
1 Arch Pediatr
3 Arerugi
2 BMJ
1 Br J Dermatol
2 Contact Dermatitis
2 Int Arch Allergy Immunol
2 J Allergy Clin Immunol
2 J Am Acad Dermatol
1 J Dermatol
2 J Invest Dermatol
5 N Engl J Med


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Derm Venereol

  1. TRAVE I, Salvi I, Bagnasco D, Parodi A, et al
    Tralokinumab as an Alternative to Dupilumab in a Patient with Atopic Dermatitis and Asthma who Developed Hypereosinophilia: A Case Report.
    Acta Derm Venereol. 2024;104:adv40800.
    PubMed        


    Allergy

  2. SANTOS AF, Riggioni C, Du Toit G, Skypala I, et al
    An algorithm for the diagnosis and management of IgE-mediated food allergy, 2024 update.
    Allergy. 2024 Sep 20. doi: 10.1111/all.16321.
    PubMed        

  3. ZHOU X, Dunham D, Sindher SB, Long A, et al
    HLA-DR(+) regulatory T cells and IL-10 are associated with success or failure of desensitization outcomes.
    Allergy. 2024 Sep 18. doi: 10.1111/all.16311.
    PubMed         Abstract available

  4. ARASI S, Cafarotti A, Galletta F, Panetta V, et al
    Omalizumab reduces anaphylactic reactions and allows food introduction in food-allergic in children with severe asthma: An observational study.
    Allergy. 2024 Sep 16. doi: 10.1111/all.16314.
    PubMed         Abstract available

  5. VON BORSTEL A, Reinwald S, Aui PM, McKenzie CI, et al
    Expansion of phenotypically modified type 2 memory B cells after allergen immunotherapy.
    Allergy. 2024 Sep 13. doi: 10.1111/all.16320.
    PubMed        


    Allergy Asthma Proc

  6. BELLANTI JA, Settipane RA
    Essentials of an immunodeficiency primer: A practical reference for the allergist/immunologist and the allergy-immunology fellow-in-training (FIT).
    Allergy Asthma Proc. 2024;45:291-293.
    PubMed        


    Am J Respir Crit Care Med

  7. MELEN E, Zar HJ, Siroux V, Shaw D, et al
    Asthma Inception: Epidemiologic Risk Factors and Natural History Across the Life-Course.
    Am J Respir Crit Care Med. 2024 Jul 9. doi: 10.1164/rccm.202312-2249.
    PubMed         Abstract available

  8. KABATA H, Ueki S
    Unveiling the Neuron-Mediated ILC2 Activation in Human Asthma.
    Am J Respir Crit Care Med. 2024 May 31. doi: 10.1164/rccm.202404-0844.
    PubMed        

  9. JU X, Nagashima A, Dvorkin-Gheva A, Wattie J, et al
    Neuromedin-U Mediates Rapid Activation of Airway Group 2 Innate Lymphoid Cells in Mild Asthma.
    Am J Respir Crit Care Med. 2024 Apr 10. doi: 10.1164/rccm.202311-2164.
    PubMed         Abstract available

  10. KING CS, Ignacio RV, Khangoora V, Nyquist A, et al
    Hospitalization Rates in Interstitial Lung Disease: An Analysis of the Pulmonary Fibrosis Foundation Registry.
    Am J Respir Crit Care Med. 2024;210:801-813.
    PubMed         Abstract available


    Ann Allergy Asthma Immunol

  11. WILSON BE, Wright BL, Swing T, Schroeder S, et al
    Eosinophilic esophagitis in Native American children and young adults: A case control study.
    Ann Allergy Asthma Immunol. 2024;133:476-480.
    PubMed        

  12. MCCARTY ME, Fajt ML, Gershuni LS, Petrov AA, et al
    A retrospective study of a novel 3-session rush venom immunotherapy protocol.
    Ann Allergy Asthma Immunol. 2024;133:462-468.
    PubMed         Abstract available

  13. CHIARELLA SE, Garcia-Guaqueta DP, Drake LY, Dixon RE, et al
    Sex differences in sociodemographic, clinical, and laboratory variables in childhood asthma: A birth cohort study.
    Ann Allergy Asthma Immunol. 2024 Jul 15:S1081-1206(24)00426.
    PubMed         Abstract available

  14. CORELLI ER, Peebles RS Jr
    Race toward more equitable pulmonary function testing?
    Ann Allergy Asthma Immunol. 2024;133:362-363.
    PubMed        

  15. BERNSTEIN JA, Silver J, Packnett E, Lew CR, et al
    Real-world unified airway benefits of mepolizumab: effectiveness in patients with asthma and comorbid nasal polyps.
    Ann Allergy Asthma Immunol. 2024 Jul 5:S1081-1206(24)00421.
    PubMed         Abstract available

  16. GULTEKIN TTK, Emeksiz ZS, Selmanoglu A, Misirlioglu ED, et al
    Nonsteroidal anti-inflammatory drug-induced fixed urticaria: First pediatric case report.
    Ann Allergy Asthma Immunol. 2024;133:470-472.
    PubMed        

  17. HORNER AA, Land MH, Abolhosn R, Stern J, et al
    Blood stored in EDTA tubes provides accurate peanut basophil activation test results for 48 hours.
    Ann Allergy Asthma Immunol. 2024;133:445-452.
    PubMed         Abstract available

  18. ADELEKE S, Ongtengco A, Youssef C, Hardy P, et al
    Addressing Critical Barriers for Sustainability of Asthma Stock Inhaler Policy Implementation and Resultant Programming.
    Ann Allergy Asthma Immunol. 2024 Jun 26:S1081-1206(24)00373.
    PubMed         Abstract available

  19. CHU AWL, Rayner DG, Chu X, Chen L, et al
    Topical corticosteroids for hives and itch (urticaria): Systematic review and Bayesian meta-analysis of randomized trials.
    Ann Allergy Asthma Immunol. 2024;133:437-444.
    PubMed         Abstract available

  20. MIN TK, Saini SS
    The future of targeted therapy in chronic spontaneous urticaria.
    Ann Allergy Asthma Immunol. 2024;133:367-373.
    PubMed         Abstract available

  21. FITZPATRICK AM, Mohammad AF, Desher K, Mutic AD, et al
    Clinical and inflammatory features of traffic-related diesel exposure in children with asthma.
    Ann Allergy Asthma Immunol. 2024 Jul 27:S1081-1206(24)00457.
    PubMed         Abstract available

  22. SOTO-RETES L, Milagro J, Crespo-Lessmann A, Curto E, et al
    Parasympathetic nervous system: a key role in control and mood disorders in patients with asthma.
    Ann Allergy Asthma Immunol. 2024 Jul 27:S1081-1206(24)00480.
    PubMed         Abstract available

  23. LIEBERMAN JA
    The landscape of novel therapies for urticaria and angioedema.
    Ann Allergy Asthma Immunol. 2024;133:355.
    PubMed        

  24. WEINBERGER MM, Hendeles L
    Biologics for asthma and comorbid nasal polyps.
    Ann Allergy Asthma Immunol. 2024;133:356-357.
    PubMed        

  25. GOODMAN GM
    Topical corticosteroids for urticaria: A look at the evidence we have.
    Ann Allergy Asthma Immunol. 2024;133:358-359.
    PubMed        

  26. GOLDEN DBK, Tracy JM
    Venom immunotherapy: What is the rush?
    Ann Allergy Asthma Immunol. 2024;133:360-361.
    PubMed        

  27. TONG WH
    Comment on "Multiple reactions during desensitization may predict decreased efficacy of PEGasparaginase chemotherapy".
    Ann Allergy Asthma Immunol. 2024;133:484-485.
    PubMed        

  28. PERLMAN L, Gabrielli S, Clarke AE, Colli LD, et al
    Management of Anaphylaxis Following Pre-Hospital Epinephrine Use in Children with Food-induced Anaphylaxis.
    Ann Allergy Asthma Immunol. 2024 Sep 18:S1081-1206(24)01528.
    PubMed         Abstract available

  29. SMITH TD, Riedl MA
    The future of therapeutic options for hereditary angioedema.
    Ann Allergy Asthma Immunol. 2024;133:380-390.
    PubMed         Abstract available

  30. PUXEDDU I, Pistone F, Pisani F, Levi-Schaffer F, et al
    Mast cell signaling and its role in urticaria.
    Ann Allergy Asthma Immunol. 2024;133:374-379.
    PubMed         Abstract available


    Arch Pediatr

  31. RIGOURD V, Heneau A, Virlouvet AL, Basset A, et al
    Indications for extensively hydrolyzed cow's milk protein in the neonatal period.
    Arch Pediatr. 2024 Jul 13:S0929-693X(24)00086.
    PubMed         Abstract available


    Arerugi


  32. JSA-JSI Joint Session.
    Arerugi. 2024;73.
    PubMed        


  33. JSA-DGAKI Joint Meeting.
    Arerugi. 2024;73.
    PubMed        


  34. East Asia Allergy Symposium 2024.
    Arerugi. 2024;73.
    PubMed        


    BMJ

  35. BANSAL A, Franklin L, Twohig H
    Optimising inhaled therapy for patients with asthma.
    BMJ. 2024;386:e080353.
    PubMed        

  36. CREAMER D, Lumb T, Tibbles CD, Lee HY, et al
    Stevens-Johnson syndrome/toxic epidermal necrolysis: initial assessment.
    BMJ. 2024;386:e079986.
    PubMed        


    Br J Dermatol

  37. HUBENTHAL M, Dai C, Brown SJ, Heinrich L, et al
    Mapping SCORing of Atopic Dermatitis (SCORAD) and objective SCORAD to the Eczema Area and Severity Index to facilitate large-scale meta-analyses of molecular data.
    Br J Dermatol. 2024;191:637-639.
    PubMed        


    Contact Dermatitis

  38. LORETAN A, Bertone F, Menzinger S, Piletta P, et al
    Severe allergic contact dermatitis caused by methoxypropylamino cyclohexenylidene ethoxyethylcyanoacetate.
    Contact Dermatitis. 2024 Sep 21. doi: 10.1111/cod.14700.
    PubMed        

  39. GOESSINGER EV, Merkel T, Chantraine S, Hartmann K, et al
    Extensive allergic contact dermatitis to dexpanthenol with distant facial and symmetrical intertriginous involvement: An unusual clinical presentation.
    Contact Dermatitis. 2024 Sep 16. doi: 10.1111/cod.14693.
    PubMed        


    Int Arch Allergy Immunol

  40. ZENG Z, Ruan Y, Ying H, Wang J, et al
    Baicalin Attenuates Type 2 Immune Responses in a Mouse Allergic Asthma Model through Inhibiting the Production of Thymic Stromal Lymphopoietin.
    Int Arch Allergy Immunol. 2024 Sep 19:1-9. doi: 10.1159/000541100.
    PubMed         Abstract available

  41. YIM Y, Jo H, Park S, Son Y, et al
    Sex-Specific and Long-Term Trends of Asthma, Allergic Rhinitis, and Atopic Dermatitis in South Korea, 2007-2022: A Nationwide Representative Study.
    Int Arch Allergy Immunol. 2024 Sep 16:1-18. doi: 10.1159/000540928.
    PubMed         Abstract available


    J Allergy Clin Immunol

  42. RURAN HB, Mallouh BL, Bartnikas LM, Phipatanakul W, et al
    Disparities in Allergy and Asthma Prevalence Among School Teachers.
    J Allergy Clin Immunol. 2024 Sep 18:S0091-6749(24)00978.
    PubMed         Abstract available

  43. MARTIN-CRUZ L, Benito-Villalvilla C, Angelina A, Subiza JL, et al
    Trained immunity-based vaccines for infections and allergic diseases.
    J Allergy Clin Immunol. 2024 Sep 18:S0091-6749(24)00979.
    PubMed         Abstract available


    J Am Acad Dermatol

  44. ELGHAZZAWY MB, Nassir S, Arora JS, Min MS, et al
    A retrospective cohort study investigating cutaneous vasculitis in the setting of COVID-19 notes higher rates of IgA vasculitis.
    J Am Acad Dermatol. 2024;91:757-759.
    PubMed        

  45. OBIJIOFOR CE, Sikora M, Liu L, Stern MJ, et al
    Investigating corrected QT prolongation with hydroxychloroquine use among patients with cutaneous sarcoidosis: A multicenter retrospective study.
    J Am Acad Dermatol. 2024;91:740-742.
    PubMed        


    J Dermatol

  46. IGARASHI A, Tsuji G, Fukasawa S, Murata R, et al
    Tapinarof cream for the treatment of atopic dermatitis: Efficacy and safety results from two Japanese phase 3 trials.
    J Dermatol. 2024 Sep 13. doi: 10.1111/1346-8138.17451.
    PubMed         Abstract available


    J Invest Dermatol

  47. CASSAGNE M, Galiacy S, Kychygina A, Chapotot E, et al
    Superficial Conjunctival Cells from Dupilumab-treated Atopic Dermatitis Patients with Ocular Adverse Events Display a Transcriptomic Psoriasis Signature.
    J Invest Dermatol. 2024 Sep 19:S0022-202X(24)02102.
    PubMed         Abstract available

  48. XIA E, Gaurav A, Noe MH, Mostaghimi A, et al
    Validation of the Diagnostic Code for Cutaneous Sarcoidosis in an Electronic Health Database: a Cross-sectional Analysis.
    J Invest Dermatol. 2024 Mar 26:S0022-202X(24)00212.
    PubMed        


    N Engl J Med

  49. ROTHENBERG ME, Dellon ES, Collins MH
    Two Clinical Trials Assessing Treatments for Eosinophilic Esophagitis. Reply.
    N Engl J Med. 2024;391:1067-1068.
    PubMed        

  50. CHEHADE M, Dellon ES, Spergel JM
    Two Clinical Trials Assessing Treatments for Eosinophilic Esophagitis. Reply.
    N Engl J Med. 2024;391:1066-1067.
    PubMed        

  51. MENNINI M, Parisi P, Di Nardo G
    Two Clinical Trials Assessing Treatments for Eosinophilic Esophagitis.
    N Engl J Med. 2024;391:1066.
    PubMed        

  52. LIN CH
    Two Clinical Trials Assessing Treatments for Eosinophilic Esophagitis.
    N Engl J Med. 2024;391:1065-1066.
    PubMed        

  53. CHAO CY, Chao HH, Yong SB
    Two Clinical Trials Assessing Treatments for Eosinophilic Esophagitis.
    N Engl J Med. 2024;391:1065.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.